ArticleCureus2026
A Case of Thyroid Dermopathy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid dermopathy is a relatively uncommon extrathyroidal manifestation of autoimmune thyroid disease in which there is localized thickening of the skin due to accumulation of glycosaminoglycans. Thyroid dermopathy is classified as a cutaneous mucinosis and is thought to occur in less than 5% of all patients with Graves' disease, most commonly in the setting of severe thyroid eye disease. We present a case of a forty-year-old woman with long-standing Graves' disease and thyroid eye disease who developed progressive thyroid dermopathy over years. Despite partial response to intralesional glucocorticoid and hyaluronidase, definitive symptom control was not obtained until immunomodulatory therapy was started for other concomitant autoimmune conditions. Here we present a case of significant thyroid dermopathy that responded well to systemic immunomodulatory therapy that was prescribed for concomitant autoimmune conditions. This case underscores the diagnostic challenges and limited treatment options for thyroid dermopathy and discusses the potential role for systemic therapy in more advanced disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.